Market Scenario

China Medical Plastic Packaging Market is estimated to witness a rise in revenue from US$ 4,317.8 Mn in 2021 to US$ 6,777.8 Mn by 2027. The market is registering a CAGR of 7.8% during the forecast period 2022-2027. In terms of volume, the market is registering a CAGR of 7.1% during the forecast period 2022-2027. 

From drug packaging to packaging for medical devices, plastics are essential to ensure the safety of healthcare workers and their patients. Plastics keep medical devices clean and protected and are inert so they don’t interact with the device or drug. In return, these medical devices do not expose us to disease contamination and infections. Moreover, plastics have a wide range of applications since they are both cost-effective and safe medical disposals. Products with PCR content and bioplastics which are non-reactant and eco-friendly are likely to become popular.

The major factor responsible for the growth of the China medical plastic packaging market includes the surging incidence of lifestyle-related chronic diseases and awareness among individuals toward the benefits of packaged healthcare and rising demand for plastic packaging in the healthcare & pharmaceutical industry. Moreover, new investments in plastic recycling capabilities in healthcare creates a lucrative growth opportunity in the market. The use of plastic packaging in the healthcare industry is predicted to increase as a result of increased government financing for healthcare and drug development facilities. However, stringent regulatory norms on plastics usage are expected to restrict the growth of the China medical plastic packaging market.

Report Summary

The study of the China Medical Plastic Packaging Market considers various market determinants, industry value chain analysis and competitor analysis of the market. The report discusses the analysis of the medical plastic packaging industry for the period 2017-2027, where the base year is 2021 and the forecast period is 2022-2027. The report provides a detailed analysis of the China Medical Plastic Packaging Market across 9 Chapters and 115 pages. The report includes data presentation across 12 tables and 27 statistical figures.

The report provides PESTLE analysis, which is a tool to examine the external market environment factors that have an impact on the industry. The PESTLE analysis examines the Political, Economic, Social, Technological, Environmental and Legal factors in the external environment. Thus, sufficiently examining the threats and weaknesses of the industry. The research report also provides Porter’s five forces analysis wherein bargaining power of buyers is moderate and competitive rivalry is high.

The subsequent section provides details of the market analysis based on different segments such as plastic type, packaging type, drug type and end user. The report includes detailed study of value chain of the industry. It includes raw material providers, manufacturing, distributors and end users. The report also covers extensively about the key competitors in the market for medical plastic packaging.

Impact of COVID-19 on China Medical Plastic Packaging Market

China Medical Plastic Packaging market witnessed growth in 2020, in the recent outbreak of the COVID-19 pandemic. The COVID-19 outbreak has directly affected the packaging industry in a positive way, as the demand for cost-effective, high-quality and efficient healthcare packaging solutions have increased. The outbreak of COVID-19 in China and other countries has created a huge product demand from applications such as testing equipment, medical bags, gloves, masks, ventilators, syringes, surgical drapes and Personal Protective Equipment (PPE). Thus, the rising cases of COVID-19 in the region are projected to substantially drive the market growth. 

Regulations / Standard of China Medical Supplies

• China National Medical Products Administration (NMPA)

The statutory body regulates medical devices and pharmaceutical products across China. The NMPA was also known as China Food and Drug Administration in the past. Specifically, NMPA creates, supervises and implements policies and standards governing medical devices, cosmetics and drugs. The agency also oversees the registration process as well as inspections for these products.

• Center for Medical Device Evaluation (CMDE)

The Center for Medical Device Evaluation (CMDE) is responsible for conducting the dossier review during the medical device registration process. It stipulates registration withdrawal and re-application procedures for imported medical devices that were submitted for registration as Class II device​s but upon technical review were found to fall into Class III.

Key Takeaways from the China Medical Plastic Packaging Market Report

• Based on plastic type, the PP segment holds the largest market share in 2021 as it is a primary material that is used for plastic packaging bags in express delivery in the region. Whereas, LDPE segment is anticipated to grow at the highest CAGR of 9.5% during the forecast period.
• On the basis of packaging type, the primary segment dominated the China medical plastic packaging market in 2021. Whereas, tertiary segment is anticipated to project the highest CAGR over the forecast period as this type of packaging are easier to transport the large and heavy loads safely and securely.
• In terms of drug type, the devices segment holds the significant share in the market in 2021. Moreover, the nasal segment is projected to grow at the highest CAGR in the market over forecast period.
• By end user, the pharma manufacturing segment holds the largest share in 2021. Whereas, the contract packaging segment is expected to project the highest CAGR of 8.8% over the forecast period due of growing trend for contract-based work in the medical industry.

Competitive Landscape

The key players in the China Medical Plastic Packaging Market are Amcor Plc, FLEX Ltd., EVCO Plastics, Gerresheimer AG, Hebei Xinfuda Plastic Products Co. Ltd., Linuo Group, Sanner GMBH, Shandong Pharmaceutical Glass Co. Ltd., Sichuan Kelun Pharmaceutical Co, Ltd., Tongyu Pharmaceutical Packaging Co, Ltd, Hangzhou Plastics Industry Co., Ltd. And Hebei First Rubber Medical Technology Co., Ltd. among others. Through extensive research, it is found that big players have adopted various competitive strategies such as mergers & acquisitions in order to have a grip of emerging market. Furthermore, leading companies are expanding their geographical boundaries by acquiring small brands and domestic companies.

Segmentation Overview 

China Medical Plastic Packaging Market is segmented based on plastic type, packaging type, drug type and end user. The industry trends in the medical plastic packaging market are sub-divided into different categories in order to get a holistic view of the China marketplace. 

Following are the different segments of the China Medical Plastic Packaging Market:

The Plastic Type segment of the China Medical Plastic Packaging Market is sub-segmented into:

• PET
• PP
• LDPE
• HDPE
• Others

By Packaging Type segment of the China Medical Plastic Packaging Market is sub-segmented into:

• Primary
  • Vials
  • Ampoules
  • Blisters
  • Caps & Closures
  • Syringe
  • Sachet
  • Bottles
  • Others
• Secondary
  • Cartons
  • Boxes
  • Injection Trays
• Tertiary 

By Drug Type segment of the China Medical Plastic Packaging Market is sub-segmented into:

• Oral Drugs
• Injectables
• Topical
• Ocular/ Ophthalmic
• Nasal
• Sublingual
• Pulmonary
• Transdermal
• IV Drugs
• Devices
• Others

By End User segment of the China Medical Plastic Packaging Market is sub-segmented into:

• Pharma Manufacturing
• Contract Packaging
• Retail Pharmacy
• Institutional Pharmacy